Immature erythroid cells: A new source for therapeutic angiogenesis?

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 3, 2010, Pages 341-342

  Takahashi, Masafumi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ERYTHROPOIETIN;

ANGIOGENESIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BURST FORMING UNIT; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL TRIAL; EDITORIAL; ERYTHROID CELL; HEART MUSCLE ISCHEMIA; HUMAN; INCUBATION TIME; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL EXPANSION; THROMBOCYTE FUNCTION; TREATMENT RESPONSE;

EID: 77955272374     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.05.008     Document Type: Editorial

References (20)

1. Jia L., Takahashi M., Yoshioka T., Morimoto H., Ise H., Ikeda U. Therapeutic potential of endothelial progenitor cells for cardiovascular diseases. Curr Vasc Pharmacol 2006, 4:59-65.
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
4. Shiba Y., Takahashi M., Hata T., Murayama H., Morimoto H., Ise H., et al. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis. Cardiovasc Res 2009, 81:169-177.
5. Tateno K., Minamino T., Toko H., Akazawa H., Shimizu N., Takeda S., et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006, 98:1194-1202.
6. Kim S.W., Han H., Chae G.T., Lee S.H., Bo S., Yoon J.H., et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006, 24:1620-1626.
7. Dash N.R., Dash S.N., Routray P., Mohapatra S., Mohapatra P.C. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 2009, 12:359-366.
8. Murohara T., Shintani S., Kondo K. Autologous adipose-derived regenerative cells for therapeutic angiogenesis. Curr Pharm Des 2009, 15:2784-2790.
9. Sieveking D.P., Buckle A., Celermajer D.S., Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008, 51:660-668.
10. Oda M, Toba K, Ozawa T, Kato K, Yanagawa T, Ikarashi N, et al. Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia. J Mol Cell Cardiol. in press.
11. Ozawa T., Toba K., Kato K., Minagawa S., Saigawa T., Hanawa H., et al. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J Mol Cell Cardiol 2006, 40:629-638.
12. Tordjman R., Delaire S., Plouet J., Ting S., Gaulard P., Fichelson S., et al. Erythroblasts are a source of angiogenic factors. Blood 2001, 97:1968-1974.
13. Bernard J. The erythroblastic island: past and future. Blood Cells 1991, 17:5-10. discussion -4.
14. Sasaki S., Inoguchi T., Muta K., Abe Y., Zhang M., Hiasa K., et al. Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells. Am J Physiol Heart Circ Physiol 2007, 292:H657-H665.
15. Hirata A., Minamino T., Asanuma H., Fujita M., Wakeno M., Myoishi M., et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 2006, 48:176-184.
16. Rafii D.C., Psaila B., Butler J., Jin D.K., Lyden D. Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2008, 28:217-222.
17. Takahashi M., Izawa A., Ishigatsubo Y., Fujimoto K., Miyamoto M., Horie T., et al. Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases. Curr Pharm Des 2009, 15:2778-2783.
18. Matoba S., Matsubara H. Therapeutic angiogenesis for peripheral artery diseases by autologous bone marrow cell transplantation. Curr Pharm Des 2009, 15:2769-2777.
19. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422-3427.
20. Iwase T., Nagaya N., Fujii T., Itoh T., Murakami S., Matsumoto T., et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 2005, 66:543-551.